Integrating Molecular Mechanisms, Immunotherapy, and Drug Sensitivity in Cancer Immunology and Oncology

25k
Total downloads
97k
Total views and downloads

Articles

ORIGINAL RESEARCH

Accepted on 26 Sep 2025

Chromosome 11q13 Amplification as a Decision-Making Biomarker for Anti-PD-1 Immunotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study

Wen Jiang
Shengjin Dou
Lin Zhang
Minjun Dong
Jiang Li
Ge Wang
Ziyue Gu
Yining HE
Debin Sun
1 more
Guopei Zhu

doi 10.3389/fimmu.2025.1667733

ORIGINAL RESEARCH

Published on 22 Sep 2025

SLFN11 expression correlates with immune microenvironment and predicts prognosis in melanoma

Huancheng Zeng
Guishan Chen
Yutong Fang
Jundong Wu
Qiongzhi Jiang
Rendong Zhang

doi 10.3389/fimmu.2025.1607056

1,605 views

ORIGINAL RESEARCH

Published on 03 Sep 2025

Physicochemical and biological characterization of a bispecific antibody in a CrossMab/KIH format that targets EGFR and VEGF-A

Safiat Ayinde
Shraboni Dutta
Nishant Mohan
Wen Jin Wu

doi 10.3389/fimmu.2025.1659966

1,206 views

MINI REVIEW

Published on 01 Sep 2025

Sepsis-driven metabolic reprogramming shapes cancer immunotherapy efficacy, metastatic potential, and drug sensitivity

Leyi Wang
Changdong Wu
Ming Hou
Zhiwei Li

doi 10.3389/fimmu.2025.1642477

618 views

ORIGINAL RESEARCH

Published on 24 Jul 2025

Identification of a coagulation-related classification and signature that predict disease heterogeneity for colorectal cancer and pan-cancer patients

Junpeng Pei
Yuye Gao
Baojian Xing
Yongjiu Chen
Aiwen Wu

doi 10.3389/fimmu.2025.1572701

1,222 views

ORIGINAL RESEARCH

Published on 15 Jul 2025

Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer

Meiling Gao
Jiahao Qian
Ping Xia
Wancheng Liu
Yunjia Jiang
Yuchang Xia
Xin Yao
Qingqing Jiao
Minggang Wei

doi 10.3389/fimmu.2025.1593639

1,624 views

ORIGINAL RESEARCH

Published on 14 Jul 2025

Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study

Jian Chen
Haijuan Yu
Yingtao Lin
Dan Hu
Li Liu
Renliang Fan
Jianping Zou
Lele Zang
Yao Lin
15 more
Yang Sun

doi 10.3389/fimmu.2025.1611696

1,522 views

ORIGINAL RESEARCH

Published on 26 Jun 2025

Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model

Zhouzhou Xie
Shansen Peng
Jiongming Wang
Yueting Huang
Xiaoqi Zhou
Guihao Zhang
Huiming Jiang
Kaihua Zhong
Lingsong Feng
Nanhui Chen

doi 10.3389/fimmu.2025.1602898

2,267 views

ORIGINAL RESEARCH

Published on 24 Jun 2025

Taurine-mediated metabolic immune crosstalk indicates and promotes immunosuppression with anti-PD-1 resistance in bladder cancer

Zhengfang Liang
Fengwei Nong
Zhenjie Li
Runmin Chen
Haoxu Zhao
Yongping Huang

doi 10.3389/fimmu.2025.1618439

2,385 views
1 citation

ORIGINAL RESEARCH

Published on 09 Jun 2025

Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status

Yongtao Li
Tangnuer Buerliesi
Wenting Xu
Lina Yi
Fulati Wuwalihan

doi 10.3389/fonc.2025.1596156

1,269 views

REVIEW

Published on 21 May 2025

Dissecting the dual role of OTU family proteins in tumor progression and immune escape

Xiaolong Tang
Yadan Li
Yongshuo Liu

doi 10.3389/fimmu.2025.1544341

1,516 views

ORIGINAL RESEARCH

Published on 13 May 2025

Glypican-3 regulated epithelial mesenchymal transformation-related genes in osteosarcoma: based on comprehensive tumor microenvironment profiling

Jiaming Zhang
Wei Wang

doi 10.3389/fimmu.2025.1566061

1,369 views

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.3 impact factor
- 6.9 citescore

Impact

97kTopic views
67kArticle views
25kArticle downloads

View impact

Articles

Chromosome 11q13 Amplification as a Decision-Making Biomarker for Anti-PD-1 Immunotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study

SLFN11 expression correlates with immune microenvironment and predicts prognosis in melanoma

Physicochemical and biological characterization of a bispecific antibody in a CrossMab/KIH format that targets EGFR and VEGF-A

Sepsis-driven metabolic reprogramming shapes cancer immunotherapy efficacy, metastatic potential, and drug sensitivity

Identification of a coagulation-related classification and signature that predict disease heterogeneity for colorectal cancer and pan-cancer patients

Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer

Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study

Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model

Taurine-mediated metabolic immune crosstalk indicates and promotes immunosuppression with anti-PD-1 resistance in bladder cancer

Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status

Dissecting the dual role of OTU family proteins in tumor progression and immune escape

Glypican-3 regulated epithelial mesenchymal transformation-related genes in osteosarcoma: based on comprehensive tumor microenvironment profiling

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Participating Journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy